Page last updated: 2024-09-03

heptakis(2,6-o-dimethyl)beta-cyclodextrin and acebutolol

heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with acebutolol in 3 studies

Compound Research Comparison

Studies
(heptakis(2,6-o-dimethyl)beta-cyclodextrin)
Trials
(heptakis(2,6-o-dimethyl)beta-cyclodextrin)
Recent Studies (post-2010)
(heptakis(2,6-o-dimethyl)beta-cyclodextrin)
Studies
(acebutolol)
Trials
(acebutolol)
Recent Studies (post-2010) (acebutolol)
1480454,9621971,292

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahsan, F; Arnold, JJ; Meezan, E; Pillion, DJ; Schwiebert, EM; Yang, T1
Ahsan, F; Hussain, A; Yang, T; Zaghloul, AA1
Ahsan, F; Bai, S; Mustafa, F; Yang, T1

Other Studies

3 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and acebutolol

ArticleYear
Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-).
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2003, Volume: 20, Issue:1

    Topics: Adjuvants, Pharmaceutic; beta-Cyclodextrins; Biological Transport; Bronchi; Cells, Cultured; Cyclodextrins; Humans; Insulin; Maltose; Mannitol; Permeability; Respiratory Mucosa; Time Factors

2003
Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin.
    Pharmaceutical research, 2003, Volume: 20, Issue:10

    Topics: Absorption; Adjuvants, Pharmaceutic; Animals; beta-Cyclodextrins; Biological Availability; Blood Glucose; Cyclodextrins; Instillation, Drug; Insulin; Lung; Male; Maltose; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Time Factors; Trachea

2003
Pulmonary delivery of low molecular weight heparins.
    Pharmaceutical research, 2004, Volume: 21, Issue:11

    Topics: Animals; Anticoagulants; beta-Cyclodextrins; Biological Transport, Active; Bronchi; Cell Line; Chemistry, Pharmaceutical; Dalteparin; Dose-Response Relationship, Drug; Drug Delivery Systems; Electric Conductivity; Enoxaparin; Epithelial Cells; Factor Xa; Heparin, Low-Molecular-Weight; Humans; Lung; Male; Maltose; Rats; Rats, Sprague-Dawley; United States

2004